A Bioprocess Design for Microbial Production of Taxol

Project Summary

Paclitaxel (Taxol) is a small molecule drug belonging to the taxane family. It is one of the most commonly used chemotherapeutics, used for treatment of many cancers, as a monotherapy or in combination with other drugs to treat breast, lung and ovarian cancer as well as Kaposi’s sarcoma. Taxol is on the World Health Organization’s (WHO) List of Essential Medicines, a list that includes most the important medications for basic health. The worldwide demand for paclitaxel is exceeding the current supply. 

Themes and Categories
Health
Health Systems Operations
Year
2015

In addition the current cost of paclitaxel limits use in many parts of the developing world. Lower cost sources of paclitaxel can have an immediate impact to human health worldwide. Currently taxol is approved in the U.S. as first line of treatment for breast, ovarian and non-small cell lung cancer. The annual new cases of these cancers are ~ 540,000 in the United States.

Project Team

  • Banskota, S.
  • Ciesla T.J.
  • Moreb, E.

BME 590-02 Fall 2015 

Project Details

Market size: U.S. market : 1,100 kg per year

Process design included:

  • Genetically engineered E. coli Strain
  • Heterologous Taxol production pathway
  • Engineered host strain
  • GMP fermentation process
  • 5 step downstream recovery process 

Results

Our conceptual design results in cost competitive production 

  • $0.43/mg - including a 25% return
  • ~$ 5M in capital investment
  • Current pricing is ~ $0.50/mg 

Download the project poster for more details (PDF).

Related People

Related Projects

Big Data for Reproductive Health (BD4RH Year 2)

Dennis Harrsch, Jr. ( Computer Science ), Elizabeth Loschiavo ( Sociology ), and Zhixue (Mary) Wang ( Computer Science, Statistics ) spent ten weeks improving upon the team’s web platform that allows users to examine contraceptive use in low and middle income (LMIC) countries collected by the Demographic and Health Survey (DHS) contraceptive calendar. The team improved load times, data visualization latency, and increased the number of country surveys available in the platform from 3 to 55. The team also created a new app that allows users to explore the results of machine learning using this big data set.

This project will continue into the academic year via Bass Connections where student teams will refine the machine learning model results and explore the question of whether and how policymakers can use these tools to improve family planning in LMIC settings.

 

Click here to view the Executive Summary

 

Faculty Lead: Megan Huchko

Project Manager: Amy Finnegan

Urodynamic Data and Machine Learning

Nathaniel Choe (ECE) and Mashal Ali (Neuroscience) spent ten weeks developing machine-learning tools to analyze urodynamic detrusor pressure data of pediatric spina bifida patients from the Duke University Hospital. The team built a pipeline that went from raw time series data to signal analysis to dimension reduction to classification, and has the potential to assist in clinician diagnosis.

 

Click here to read the Executive Summary

 

Faculty Leads: Wilkins Aquino, Jonathan Routh

Project Manager: Zekun Cao

Optimizing Risk Assessment for Duke University Student Athlete Injury Prevention

Maria Henriquez (Computer Science, Statistics) and Jacob Sumner (Biology) spent ten weeks building tools to help the Michael W. Krzyzewski Human Performance Lab best utilize its data from Duke University student athletes. The team worked with a large collection of athlete strength, balance, and flexibility measurements collected by the lab. They improved the K Lab’s data pipeline, created a predictive model for injury risk, and developed interactive web-based individualized injury risk reports.

Click here to read the Executive Summary

Faculty Lead: Dr. Tim Sell
Project Manager: Brinnae Bent

 

 

See all Research